虚拟递送认知行为疗法治疗失眠以改善癌症幸存者感知的癌症相关认知障碍的随机对照试验
加拿大西洋省份癌症幸存者中合并失眠与癌症相关认知障碍者随机接受每周7次虚拟CBT-I(n=63)或等待名单对照(n=69);治疗后CBT-I组失眠严重程度降低11.35分 vs 对照组2.67分(P<.001),感知认知障碍、认知能力及生活质量影响均改善更显著,疗效维持至随访;失眠症状改变完全中介了CBT-I对主观认知结局的效应。
要点
- CBT-I组失眠严重程度降低11.35分,对照组降低2.67分(P<.001)。
- 感知认知障碍、认知能力及生活质量影响的改善均优于对照(P<.001)。
- 失眠症状改变完全中介了CBT-I对主观认知结局的效应。
核心结论
- CBT-I治疗失眠对癌症相关认知障碍产生有临床意义且持久的改善。
- 作者认为迫切需要增加癌症中心和社区对失眠循证治疗的可及性。
研究设计与样本
- 随机对照试验,加拿大西洋省份癌症幸存者合并失眠与癌症相关认知障碍。
- 随机分配至每周7次虚拟CBT-I组(n=63)或等待名单对照组(n=69),等待期后接受治疗。
- 基线、1个月(治疗中期)和2个月(治疗后)完成评估,采用年龄和教育调整的意向性治疗混合效应模型评估治疗后变化。
- 两组数据随后合并评估3个月和6个月疗效持久性,并进行中介分析。
主要发现
- 样本平均年龄60岁,77%为女性,乳腺癌最常见(41%)。
- CBT-I组失眠严重程度降低11.35分,等待名单对照组降低2.67分(P<.001)。
- CBT-I组在感知认知障碍(P<.001;d=0.75)、认知能力(P<.001;d=0.92)和生活质量影响(P<.001;d=1.01)方面总体改善优于等待名单对照组。
- 上述改善在随访时维持。
- 失眠症状改变完全中介了CBT-I对主观认知结局的效应。
临床怎么用
- 作者认为迫切需要增加癌症中心和社区对失眠循证治疗的可及性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Comorbid insomnia and cancer-related cognitive impairment (CRCI) are experienced by up to 26% of individuals diagnosed with cancer. This study examined the efficacy and durability of cognitive behavioral therapy for insomnia (CBT-I) on perceived CRCI in cancer survivors. METHODS: Atlantic Canadian cancer survivors with insomnia and CRCI were randomly assigned to receive seven weekly virtual CBT-I sessions (n = 63) or placed in a waitlist control group (n = 69) to receive treatment after the waiting period. Participants completed assessments at baseline, 1 month (mid-treatment), and 2 months (post-treatment). Age- and education-adjusted mixed-effects models using intention-to-treat principles assessed change at post-treatment. Data from both groups were then pooled to assess the durability of effects at 3 and 6 months. A mediation analysis examined whether change in insomnia symptoms mediated the effect of CBT-I on cognitive outcomes. RESULTS: The mean age of the sample was 60 years, 77% were women, and breast cancer was the most common diagnosis (41%). The treatment group reported an 11.35-point reduction in insomnia severity, compared with a 2.67-point reduction in the waitlist control group (P < .001). The treatment group had a greater overall improvement than the waitlist control on perceived cognitive impairment (P < .001; d = 0.75), cognitive abilities (P < .001; d = 0.92), and impact on quality of life (P < .001; d = 1.01). These improvements were maintained at follow-up. Change in insomnia symptoms fully mediated the effect of CBT-I on subjective cognitive outcomes. CONCLUSION: Treating insomnia with CBT-I produces clinically meaningful and durable improvements in CRCI. There is an urgent need increase access to evidence-based treatment for insomnia in cancer centers and the community.
引用
- Garland SN, Tulk J, Savard J, et al. Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors. J Clin Oncol. 2024. PMID: 38552188. doi:10.1200/JCO.23.02330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。